701917-02-4

Basic information

• Product Name: 1H-Pyrazole-3-carboxylic acid, 4-nitro-1-phenyl-, methyl ester
• CAS NO: 701917-02-4
• Molecular Formula: C11H9N3O4
• Molecular Weight: 247.21
• Mol File: 701917-02-4.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole-3-carboxylic acid, 4-nitro-1-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-3-carboxylic acid, 4-nitro-1-phenyl-, methyl ester(701917-02-4)
• EPA Substance Registry System: 1H-Pyrazole-3-carboxylic acid, 4-nitro-1-phenyl-, methyl ester(701917-02-4)

Safety Data

• Hazardous Substances Data: 701917-02-4(Hazardous Substances Data)

Usage

Structure

Methyl ester derivative of 4-nitro-1-phenyl-1H-pyrazole-3-carboxylic acid

Usage

Organic synthesis, pharmaceutical research, and as a building block in the synthesis of biologically active compounds and pharmaceutical products

Pharmacological activities

Anti-inflammatory and antitumor activities, making it a potential candidate for drug development and medicinal applications.

Upstream product

• 1166981-47-0 methyl 4-nitro-1H-pyrazole-3-carboxylate hydrochloride 
• 98-80-6 phenylboronic acid 
• 138786-86-4 methyl 4-nitro-1H-pyrazole-3-carboxylate 

Downstream Products

• 701917-03-5 4-nitro-1-phenyl-1H-pyrazole-3-carboxylic acid 
• 701917-04-6 3-amino-4-nitro-1-phenyl-1H-pyrazole 
• 913739-29-4 tert-butyl (3-amino-1-phenyl-1H-pyrazol-4-yl)carbamate 
• 936755-48-5 2-naphthyl {4-[({4-[(tert-butoxycarbonyl)amino]-1-phenyl-1H-pyrazol-3-yl}amino)carbonyl]benzyl}carbamate 
• 936755-55-4 tert-butyl {3-[(4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoyl)amino]-1-phenyl-1H-pyrazol-4-yl} carbamate 
• 936755-56-5 tert-butyl {3-[(4-{difluoro[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl}benzoyl)amino]-1-phenyl-1H-pyrazol-4-yl} carbamate 
• 936755-57-6 tert-butyl 4-(5-{[(4-nitro-1-phenyl-1H-pyrazol-3-yl)amino]carbonyl}pyridin-2-yl)piperazine-1-carboxylate 
• 936755-30-5 benzyl {4-[({4-[(tert-butoxycarbonyl)amino]-1-phenyl-1H-pyrazol-3-yl}amino)carbonyl]benzyl}carbamate 
• 936755-29-2 tert-butyl (3-{[4-(aminomethyl)benzoyl]amino}-1-phenyl-1H-pyrazol-4-yl)carbamate 
• 936755-47-4 pyridin-3-ylmethyl {4-[({4-[(tert-butoxycarbonyl)amino]-1-phenyl-1H-pyrazol-3-yl}amino)carbonyl]benzyl}carbamate 

Relevant articles and documents

P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS

The present disclosure provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R7 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient. In another embodiment, these compounds are useful for treating respiratory dysfunction in patients by administering one or more of the compounds to a patient.

SUBSTITUTED NICOTINAMIDE COMPOUNDS

The present invention relates to a novel class of substituted nicotinamides. These compounds can inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplasti

Spirocyclic compounds

The present invention relates to a novel class of substituted spirocyclic compounds. These compounds can inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of n